Prostivac

What is a prostivac??

PROSTVAC is Bavarian Nordic’s lead targeted immunotherapy candidate that is being investigated for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).

Prostivac